PDT Partners, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$849,418
-63.6%
40,759
-58.2%
0.11%
-66.7%
Q2 2023$2,335,245
-25.7%
97,505
-41.6%
0.32%
-24.6%
Q1 2023$3,142,846
+565.0%
166,995
+462.5%
0.43%
+453.2%
Q4 2022$472,601
+24.0%
29,686
+27.5%
0.08%
+32.8%
Q3 2022$381,000
-68.9%
23,286
-73.2%
0.06%
-46.3%
Q2 2022$1,226,000
-79.3%
87,008
-64.5%
0.11%
-78.8%
Q1 2022$5,930,000
+34.3%
244,825
+29.4%
0.51%
+51.8%
Q4 2021$4,414,000
+19.1%
189,128
-15.2%
0.34%
+26.3%
Q3 2021$3,706,000
+203.8%
223,130
+346.3%
0.27%
+228.4%
Q2 2021$1,220,000
-88.5%
50,000
-90.2%
0.08%
-81.6%
Q3 2018$10,637,000
+2.2%
512,358
-24.8%
0.44%
+11.6%
Q2 2018$10,407,000
-24.2%
681,500
+11.6%
0.40%
-14.7%
Q1 2018$13,722,000
+218.7%
610,700
+405.7%
0.46%
-21.5%
Q4 2015$4,305,000
+153.1%
120,771
+134.8%
0.59%
+1452.6%
Q3 2015$1,701,000
-73.3%
51,431
-66.1%
0.04%
-77.1%
Q2 2015$6,360,000151,8520.17%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders